Unique ID issued by UMIN | UMIN000005188 |
---|---|
Receipt number | R000006158 |
Scientific Title | The effect of standard treatments in COPD patients without maintenance therapy. |
Date of disclosure of the study information | 2011/03/03 |
Last modified on | 2015/09/03 20:38:26 |
The effect of standard treatments in COPD patients without maintenance therapy.
The effect of standard treatments in COPD patients without maintenance therapy.
The effect of standard treatments in COPD patients without maintenance therapy.
The effect of standard treatments in COPD patients without maintenance therapy.
Japan |
COPD
Pneumology |
Others
NO
To investigate the efficacy and safety of standard therapy in COPD patients without maintenance therapy.
Safety,Efficacy
Change of pulmonary function (trough FEV1 and trough FVC)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine | Behavior,custom |
Maintenance therapy in accordance with Japanese COPD guideline
40 | years-old | <= |
Not applicable |
Male and Female
Diagnosis of COPD by respiratory specialist.
Not receiving of maintenance therapy with LABA, LAMA and ICS
Patients who are judged to be included in the study by investigator based on a preliminary clinical examination.
Written Informed Consent Form prior to participation in the trial.
A known hypersensitivity to the components of each standard drug for COPD.
Known diseases which contraindicate using the standard drugs for COPD according to the package insert.
Patients who are judged not to be included in the study by investigator based on a preliminary clinical examination.
Not able to follow an instruction for a smoking cessation.
A history of asthma, cystic fibrosis, bronchiectasis, interstitial lung disease, or pulmonary thromboembolic disease.
Not able to perform pulmonary function tests.
Participation in another trial with an investigational drug within 2 month prior to informed consent visit.
Pregnant or nursing women or women of childbearing potential who are not using a medically approved means of contraception.
100
1st name | |
Middle name | |
Last name | Yasuhiro Setoguchi |
Tokyo Medical University Hospital
Respiratory Medicine
6-7-1 Nishi-Shinjyuku, Shinjyuku-ku, Tokyo
+81-3-3342-6111
ystgc@tokyo-med.ac.jp
1st name | |
Middle name | |
Last name | Yasuhiro Setoguchi |
Tokyo Medical University Hospital
Respiratory Medicine
6-7-1 Nishi-Shinjyuku, Shinjyuku-ku, Tokyo
+81-3-3342-6111
ystgc@tokyo-med.ac.jp
Tokyo Medical University
Public health research center
Non profit foundation
NO
2011 | Year | 03 | Month | 03 | Day |
Published
Completed
2010 | Year | 12 | Month | 08 | Day |
2011 | Year | 03 | Month | 01 | Day |
2013 | Year | 02 | Month | 05 | Day |
2013 | Year | 03 | Month | 29 | Day |
2013 | Year | 04 | Month | 19 | Day |
2013 | Year | 04 | Month | 30 | Day |
2011 | Year | 03 | Month | 03 | Day |
2015 | Year | 09 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006158